Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Should hydroxychloroquine be stopped prior to standard or hypofractionated breast treatment?
Answer from: Radiation Oncologist at Community Practice
We don’t stop hydroxychloroquine for RT.
Sign in or Register to read more
9397
Related Questions
How do you advise patients on cardiotoxicity when they are expected to receive a low mean heart dose and low cardiac substructure doses with their radiation plan?
In patients with HER-2 positive breast cancer on pertuzumab/trastuzumab with newly developed asymptomatic brain metastases only, do you wait 3 weeks after administration of the targeted therapy to deliver SRS?
In the post-mastectomy setting, are there situations where only the regional nodes or targeted nodal basis are covered?
Is there any contraindication for a patient receiving omalizumab for treatment of her lung aspergillosis to receive adjuvant breast radiotherapy?
Do you recommend self-breast exams to your patients with history of breast cancer in addition to imaging surveillance?
Would you ever considering de-escalating therapy in any way for women with inflammatory breast cancer who had a complete pathologic response after surgery?
Would you recommend MRI post surgery and pre-irradiation for patients with extensive DCIS and close margins and how would it impact your management?
What evidence supports the use of high tangents for pN1mic breast cancer?
Would you offer APBI to a patient with very large breast anatomy and a small lumpectomy cavity after an oncoplastic closure?
Would you omit post-lumpectomy radiotherapy for high clinical risk, but low molecular risk DCIS?